Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9396 | 1159 | 42.1 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
285 | 3 | ERDOSTEINE//PEROXIREDOXIN//GLUTATHIONE | 42405 |
1788 | 2 | ALPHA LIPOIC ACID//ISOPROSTANES//LIPOIC ACID | 6335 |
9396 | 1 | ISOPROSTANES//F 2 ISOPROSTANES//NEUROPROSTANES | 1159 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ISOPROSTANES | authKW | 3362809 | 26% | 43% | 300 |
2 | F 2 ISOPROSTANES | authKW | 704848 | 7% | 31% | 85 |
3 | NEUROPROSTANES | authKW | 585476 | 3% | 67% | 33 |
4 | 8 ISO PROSTAGLANDIN F 2 ALPHA | authKW | 434404 | 3% | 57% | 29 |
5 | PHYTOPROSTANES | authKW | 363363 | 2% | 69% | 20 |
6 | 8 ISO PGF2 ALPHA | authKW | 323773 | 2% | 47% | 26 |
7 | CLAUDE PEPPER | address | 263679 | 3% | 32% | 31 |
8 | 8 EPI PGF2 ALPHA | authKW | 249774 | 1% | 59% | 16 |
9 | UMR 5074 | address | 204384 | 1% | 52% | 15 |
10 | 8 EPI PROSTAGLANDIN F 2 ALPHA | authKW | 189672 | 1% | 60% | 12 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 1644 | 33% | 0% | 388 |
2 | Endocrinology & Metabolism | 1549 | 15% | 0% | 174 |
3 | Nutrition & Dietetics | 363 | 5% | 0% | 61 |
4 | Peripheral Vascular Diseases | 310 | 6% | 0% | 64 |
5 | Cell Biology | 240 | 9% | 0% | 108 |
6 | Biochemical Research Methods | 204 | 5% | 0% | 62 |
7 | Chemistry, Organic | 203 | 8% | 0% | 88 |
8 | Pharmacology & Pharmacy | 176 | 10% | 0% | 113 |
9 | Medical Laboratory Technology | 153 | 2% | 0% | 25 |
10 | Cardiac & Cardiovascular System | 139 | 6% | 0% | 65 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLAUDE PEPPER | 263679 | 3% | 32% | 31 |
2 | UMR 5074 | 204384 | 1% | 52% | 15 |
3 | EXCELLENCE INFLAMMAT | 158995 | 1% | 46% | 13 |
4 | UMR CNRS 5074 | 107568 | 1% | 58% | 7 |
5 | CHIM BIOMOL INTERACT BIOL | 79028 | 1% | 50% | 6 |
6 | SECT GERIATR CLIN NUTR | 72948 | 1% | 46% | 6 |
7 | FI TONE P HLTHASTHMA GRP | 59274 | 0% | 75% | 3 |
8 | PHARMIBMMUMR 5247 | 59274 | 0% | 75% | 3 |
9 | SECT CLIN NUTR | 56037 | 1% | 21% | 10 |
10 | CLAUDE PEPPER AGING THER EUT | 52689 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FREE RADICAL BIOLOGY AND MEDICINE | 12123 | 5% | 1% | 63 |
2 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 9157 | 3% | 1% | 33 |
3 | FREE RADICAL RESEARCH | 8483 | 3% | 1% | 31 |
4 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 5805 | 2% | 1% | 20 |
5 | ANTIOXIDANTS & REDOX SIGNALING | 3739 | 2% | 1% | 21 |
6 | CHEMISTRY AND PHYSICS OF LIPIDS | 2061 | 1% | 0% | 16 |
7 | SKIN PHARMACOLOGY & PHYSIOLOGY | 1880 | 0% | 7% | 1 |
8 | SETAC SPECIAL PUBLICATIONS SERIES | 1383 | 1% | 1% | 8 |
9 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 1186 | 1% | 1% | 6 |
10 | REDOX REPORT | 1001 | 1% | 1% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ISOPROSTANES | 3362809 | 26% | 43% | 300 | Search ISOPROSTANES | Search ISOPROSTANES |
2 | F 2 ISOPROSTANES | 704848 | 7% | 31% | 85 | Search F+2+ISOPROSTANES | Search F+2+ISOPROSTANES |
3 | NEUROPROSTANES | 585476 | 3% | 67% | 33 | Search NEUROPROSTANES | Search NEUROPROSTANES |
4 | 8 ISO PROSTAGLANDIN F 2 ALPHA | 434404 | 3% | 57% | 29 | Search 8+ISO+PROSTAGLANDIN+F+2+ALPHA | Search 8+ISO+PROSTAGLANDIN+F+2+ALPHA |
5 | PHYTOPROSTANES | 363363 | 2% | 69% | 20 | Search PHYTOPROSTANES | Search PHYTOPROSTANES |
6 | 8 ISO PGF2 ALPHA | 323773 | 2% | 47% | 26 | Search 8+ISO+PGF2+ALPHA | Search 8+ISO+PGF2+ALPHA |
7 | 8 EPI PGF2 ALPHA | 249774 | 1% | 59% | 16 | Search 8+EPI+PGF2+ALPHA | Search 8+EPI+PGF2+ALPHA |
8 | 8 EPI PROSTAGLANDIN F 2 ALPHA | 189672 | 1% | 60% | 12 | Search 8+EPI+PROSTAGLANDIN+F+2+ALPHA | Search 8+EPI+PROSTAGLANDIN+F+2+ALPHA |
9 | IPF2 ALPHA III | 184413 | 1% | 100% | 7 | Search IPF2+ALPHA+III | Search IPF2+ALPHA+III |
10 | DIHOMO ISOPROSTANES | 158068 | 1% | 100% | 6 | Search DIHOMO+ISOPROSTANES | Search DIHOMO+ISOPROSTANES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JAHN, U , GALANO, JM , DURAND, T , (2008) BEYOND PROSTAGLANDINS - CHEMISTRY AND BIOLOGY OF CYCLIC OXYGENATED METABOLITES FORMED BY FREE-RADICAL PATHWAYS FROM POLYUNSATURATED FATTY ACIDS.ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. VOL. 47. ISSUE 32. P. 5894 -5955 | 214 | 64% | 77 |
2 | MILNE, GL , DAI, Q , ROBERTS, LJ , (2015) THE ISOPROSTANES-25 YEARS LATER.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. VOL. 1851. ISSUE 4. P. 433 -445 | 139 | 65% | 26 |
3 | BASU, S , (2008) F-2-ISOPROSTANES IN HUMAN HEALTH AND DISEASES: FROM MOLECULAR MECHANISMS TO CLINICAL IMPLICATIONS.ANTIOXIDANTS & REDOX SIGNALING. VOL. 10. ISSUE 8. P. 1405 -1434 | 158 | 61% | 123 |
4 | MONTUSCHI, P , BARNES, P , ROBERTS, LJ , (2007) INSIGHTS INTO OXIDATIVE STRESS: THE ISOPROSTANES.CURRENT MEDICINAL CHEMISTRY. VOL. 14. ISSUE 6. P. 703 -717 | 119 | 75% | 120 |
5 | VIGOR, C , BERTRAND-MICHEL, J , PINOT, E , OGER, C , VERCAUTEREN, J , LE FAOUDER, P , GALANO, JM , LEE, JCY , DURAND, T , (2014) NON-ENZYMATIC LIPID OXIDATION PRODUCTS IN BIOLOGICAL SYSTEMS: ASSESSMENT OF THE METABOLITES FROM POLYUNSATURATED FATTY ACIDS.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 964. ISSUE . P. 65 -78 | 94 | 75% | 9 |
6 | BASU, S , (2004) ISOPROSTANES: NOVEL BIOACTIVE PRODUCTS OF LIPID PEROXIDATION.FREE RADICAL RESEARCH. VOL. 38. ISSUE 2. P. 105-122 | 107 | 69% | 142 |
7 | MONTUSCHI, P , BARNES, PJ , ROBERTS, LJ , (2004) ISOPROSTANES: MARKERS AND MEDIATORS OF OXIDATIVE STRESS.FASEB JOURNAL. VOL. 18. ISSUE 15. P. 1791 -1800 | 79 | 75% | 358 |
8 | JANSSEN, LJ , (2001) ISOPROSTANES: AN OVERVIEW AND PUTATIVE ROLES IN PULMONARY PATHOPHYSIOLOGY.AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY. VOL. 280. ISSUE 6. P. L1067 -L1082 | 109 | 69% | 130 |
9 | SCHWEDHELM, E , BOGER, RH , (2003) APPLICATION OF GAS CHROMATOGRAPHY-MASS SPECTROMETRY FOR ANALYSIS OF ISOPROSTANES: THEIR ROLE IN CARDIOVASCULAR DISEASE.CLINICAL CHEMISTRY AND LABORATORY MEDICINE. VOL. 41. ISSUE 12. P. 1552-1561 | 91 | 78% | 39 |
10 | YEN, HC , WEI, HJ , LIN, CL , (2015) UNRESOLVED ISSUES IN THE ANALYSIS OF F-2-ISOPROSTANES, F-4-NEUROPROSTANES, ISOFURANS, NEUROFURANS, AND F-2-DIHOMO-ISOPROSTANES IN BODY FLUIDS AND TISSUE USING GAS CHROMATOGRAPHY/NEGATIVE-ION CHEMICAL-IONIZATION MASS SPECTROMETRY.FREE RADICAL RESEARCH. VOL. 49. ISSUE 7. P. 861 -880 | 64 | 79% | 0 |
Classes with closest relation at Level 1 |